The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comprehensive molecular analysis of phase II trial of nivolumab in patients with recurrent or metastatic carcinosarcomas.
 
Kum-Hee Yun
No Relationships to Disclose
 
Miso Kim
Honoraria - Astellas Pharma; Bristol Myers Squibb; Janssen; Merck; Ono Pharmaceutical
Consulting or Advisory Role - Astellas Pharma; Bayer; Boehringer Ingelheim; Boryung; Bristol-Myers Squibb; Janssen; Merck; MSD; Ono Pharmaceutical; Pfizer; Takeda; Yuhan
Travel, Accommodations, Expenses - Regeneron
 
Su-Jin Shin
No Relationships to Disclose
 
Jung Yong Hong
No Relationships to Disclose
 
Min Hwan Kim
Stock and Other Ownership Interests - AIMA company
Honoraria - AstraZeneca; Boryung Pharmaceuticals; Boryung Pharmaceuticals; Celltrion; Celltrion; Daiichi Sankyo; Eisai; MSD
Consulting or Advisory Role - Boryung Pharmaceuticals; Daiichi Sankyo; Eisai
Research Funding - AstraZeneca; Boryung Pharmaceuticals; Celltrion; Daewoong Pharmaceutical
 
Young Han Lee
No Relationships to Disclose
 
Jeeyun Lee
Consulting or Advisory Role - Amgen; AstraZeneca; Daichi Sankyo; Guardant Health AMEA; Immunoncia; Mirati Therapeutics; Trutino Biosciences
Research Funding - AstraZeneca; Merck Sharp & Dohme; Samsung Biopeis; Samsung Biopeis
 
Sung Hyun Kim
No Relationships to Disclose
 
Hyo Song Kim
No Relationships to Disclose